Team:UCL London/Future Vision

From 2010.igem.org

(Difference between revisions)
(Manufacturing)
(Manufacturing)
Line 23: Line 23:
[[Image:UCL-manufacture.JPG||300px|right]]
[[Image:UCL-manufacture.JPG||300px|right]]
-
The pharmaceutical industry is a trillion dollar industry. Most of the money is spent because of the inefficiency of the processes. There are still plenty of rooms of improvement on several frontiers which could potentially lead to a decrease in cost. Our project has successfully introduced a new way of increasing the reliability of batches, and removing the need for chemicals and their storage. The application of this at industrial level can reduce the cost of a bio-pharmaceutical drug, making it available to more people.
+
The pharmaceutical industry is a trillion dollar industry. Most of the money is wasted because of the inefficiency of the processes. There are still plenty of rooms of improvement on several frontiers which could potentially lead to a decrease in cost. Our project has successfully introduced a new way of increasing the reliability of batches, and removing the need for chemicals and their storage. The application of this at industrial level can reduce the cost of a bio-pharmaceutical drug, making it available to more people.
==Online/Real time monitoring==
==Online/Real time monitoring==

Revision as of 00:33, 11 October 2010

UCL IGEM 2010

RETURN TO IGEM 2010

FUTURE VISION

UCL-brainsotrm.JPG


At this stage, our main aim is to show that our circuit does in fact react in the way it does to hypoxia. Pending this achievable target, we have high hopes of our Principle being implemented in a potentially infinite number of ways. We have split them into the following main categories just to give you an idea.



Health & Medicine

UCL-blue.JPG

Imagine if the bacteria as we know it today could drive protein expression with the lack of oxygen. Synthetic biology through biochemical engineering can create the potential at which Escherichia coli cells- and we all know how harmful to humans can specific strains be- used in a twisted yet beautifully way as an expression system for the production of biopharmaceuticals. The project is based on the engineering modification of the cells and the construction of a self-induced biological circuit that allows an automated protein expression



Manufacturing

UCL-manufacture.JPG

The pharmaceutical industry is a trillion dollar industry. Most of the money is wasted because of the inefficiency of the processes. There are still plenty of rooms of improvement on several frontiers which could potentially lead to a decrease in cost. Our project has successfully introduced a new way of increasing the reliability of batches, and removing the need for chemicals and their storage. The application of this at industrial level can reduce the cost of a bio-pharmaceutical drug, making it available to more people.

Online/Real time monitoring

UCL-Green.JPG


The current method of monitoring the dissolved oxygen in a fermenter is placing several dissolved oxygen probes in different locations of the fermenter. Using the green dye gene, we can reduce the number of probes needed, and depend on a more "live" visual technique!






Retrieved from "http://2010.igem.org/Team:UCL_London/Future_Vision"